Trial Outcomes & Findings for Investigation of the Safety and Efficacy of Pocket-X Gel (NCT NCT03358251)

NCT ID: NCT03358251

Last Updated: 2020-09-02

Results Overview

Change in the probing depth of periodontal pockets which have undergone treatment with SRP+Pocket-X Gel in comparison to periodontal pockets which have undergone SRP only.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

34 participants

Primary outcome timeframe

12 and 24 weeks following first Pocket-X Gel administration

Results posted on

2020-09-02

Participant Flow

Participant milestones

Participant milestones
Measure
SRP+Pocket-X Gel, Split-mouth
The single arm is a split-mouth arm, i.e., participants will receive conventional treatment for periodontitis (scaling and root planing) for the entire mouth, and, in addition, will receive experimental treatment (Pocket-X Gel) for periodontal pockets present in one/two mouth segments (quadrants), while the contralateral quadrants will serve as control and will not undergo any further intervention.
Overall Study
STARTED
34
Overall Study
COMPLETED
34
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
SRP+Pocket-X Gel, Split-mouth
n=34 Participants
The single arm is a split-mouth arm, i.e., participants will receive conventional treatment for periodontitis (scaling and root planing) for the entire mouth, and, in addition, will receive experimental treatment (Pocket-X Gel) for periodontal pockets present in one/two mouth segments (quadrants), while the contralateral quadrants will serve as control and will not undergo any further intervention.
Age, Continuous
51.3 years
STANDARD_DEVIATION 13.1 • n=34 Participants
Sex: Female, Male
Female
13 Participants
n=34 Participants
Sex: Female, Male
Male
21 Participants
n=34 Participants
Region of Enrollment
Israel
34 participants
n=34 Participants

PRIMARY outcome

Timeframe: 12 and 24 weeks following first Pocket-X Gel administration

Change in the probing depth of periodontal pockets which have undergone treatment with SRP+Pocket-X Gel in comparison to periodontal pockets which have undergone SRP only.

Outcome measures

Outcome measures
Measure
Lower Jaw Pockets + Treatment
n=63 pockets
Periodontal pockets situated in the lower jaw which received a treatment of SRP + Pocket-X gel.
Lower Jaw Pockets - Control
n=63 pockets
Periodontal pockets situated in the lower jaw which received a tratment of SRP only.
Upper Jaw Pockets + Treatment
n=109 pockets
Periodontal pockets situated in the upper jaw which received a treatment of SRP + Pocket-X gel.
Upper Jaw Pockets + Control
n=109 pockets
Periodontal pockets situated in the upper jaw which received a treatment of SRP alone.
Change in Periodontal Pockets Probing Depth
depth at baseline
6.97 mm
Standard Deviation 1.49
6.81 mm
Standard Deviation 1.59
7.67 mm
Standard Deviation 1.45
7.72 mm
Standard Deviation 1.30
Change in Periodontal Pockets Probing Depth
depth at 3 months
5.19 mm
Standard Deviation 0.98
5.69 mm
Standard Deviation 1.38
5.53 mm
Standard Deviation 1.07
6.35 mm
Standard Deviation 1.10
Change in Periodontal Pockets Probing Depth
depth at 6 months
4.5 mm
Standard Deviation 0.8
5.53 mm
Standard Deviation 1.24
4.74 mm
Standard Deviation 0.82
7.72 mm
Standard Deviation 0.99

SECONDARY outcome

Timeframe: 12 and 24 weeks following first Pocket-X Gel administration

Change in the clinical attachment level of mouth segments which have undergone treatment with SRP+Pocket-X Gel in comparison to mouth segments which have undergone SRP only.

Outcome measures

Outcome measures
Measure
Lower Jaw Pockets + Treatment
n=63 pockets
Periodontal pockets situated in the lower jaw which received a treatment of SRP + Pocket-X gel.
Lower Jaw Pockets - Control
n=63 pockets
Periodontal pockets situated in the lower jaw which received a tratment of SRP only.
Upper Jaw Pockets + Treatment
n=109 pockets
Periodontal pockets situated in the upper jaw which received a treatment of SRP + Pocket-X gel.
Upper Jaw Pockets + Control
n=109 pockets
Periodontal pockets situated in the upper jaw which received a treatment of SRP alone.
Change in Clinical Attachment
change in CAL after 3 months
2.08 mm
Standard Deviation 0.69
0.97 mm
Standard Deviation 0.64
2.62 mm
Standard Deviation 0.82
1.26 mm
Standard Deviation 0.68
Change in Clinical Attachment
change in CAL after 6 months
3.01 mm
Standard Deviation 0.92
1.06 mm
Standard Deviation 0.63
3.61 mm
Standard Deviation 0.94
1.44 mm
Standard Deviation 0.83

SECONDARY outcome

Timeframe: 12 and 24 weeks following first Pocket-X Gel administration

Change in gingival recession level (buccal) of mouth segments which have undergone treatment with SRP+Pocket-X Gel in comparison to mouth segments which have undergone SRP only. Measured in mm.

Outcome measures

Outcome measures
Measure
Lower Jaw Pockets + Treatment
n=63 pockets
Periodontal pockets situated in the lower jaw which received a treatment of SRP + Pocket-X gel.
Lower Jaw Pockets - Control
n=63 pockets
Periodontal pockets situated in the lower jaw which received a tratment of SRP only.
Upper Jaw Pockets + Treatment
n=109 pockets
Periodontal pockets situated in the upper jaw which received a treatment of SRP + Pocket-X gel.
Upper Jaw Pockets + Control
n=109 pockets
Periodontal pockets situated in the upper jaw which received a treatment of SRP alone.
Change in Recession Level
B recession at baseline
1.36 mm
Standard Deviation 1.27
1.21 mm
Standard Deviation 1.17
1.49 mm
Standard Deviation 1.22
1.38 mm
Standard Deviation 1.06
Change in Recession Level
B recession at 3 months
1.06 mm
Standard Deviation 1.06
1.35 mm
Standard Deviation 1.32
1.01 mm
Standard Deviation 0.98
1.49 mm
Standard Deviation 1.24
Change in Recession Level
B recession at 6 months
0.82 mm
Standard Deviation 0.89
1.43 mm
Standard Deviation 1.42
0.80 mm
Standard Deviation 0.88
1.51 mm
Standard Deviation 1.38

SECONDARY outcome

Timeframe: 12 and 24 weeks following first Pocket-X Gel administration

Change in gingival bleeding index of mouth segments which have undergone treatment with SRP+Pocket-X Gel in comparison to mouth segments which have undergone SRP only.

Outcome measures

Outcome measures
Measure
Lower Jaw Pockets + Treatment
n=63 pockets
Periodontal pockets situated in the lower jaw which received a treatment of SRP + Pocket-X gel.
Lower Jaw Pockets - Control
n=63 pockets
Periodontal pockets situated in the lower jaw which received a tratment of SRP only.
Upper Jaw Pockets + Treatment
n=109 pockets
Periodontal pockets situated in the upper jaw which received a treatment of SRP + Pocket-X gel.
Upper Jaw Pockets + Control
n=109 pockets
Periodontal pockets situated in the upper jaw which received a treatment of SRP alone.
Change in Bleeding Index
percent of pockets bleeding at baseline
98.4 % percent of pockets bleeding
85.7 % percent of pockets bleeding
92.66 % percent of pockets bleeding
92.66 % percent of pockets bleeding
Change in Bleeding Index
percent of pockets bleeding after 3 months
20.63 % percent of pockets bleeding
36.51 % percent of pockets bleeding
20.18 % percent of pockets bleeding
45.87 % percent of pockets bleeding
Change in Bleeding Index
percent of pockets bleeding after 6 months
12.70 % percent of pockets bleeding
28.57 % percent of pockets bleeding
8.33 % percent of pockets bleeding
44.44 % percent of pockets bleeding

SECONDARY outcome

Timeframe: 12 and 24 weeks following first Pocket-X Gel administration

Change in mobility grade of teeth present in mouth segments which have undergone treatment with SRP+Pocket-X Gel in comparison to mouth segments which have undergone SRP only. Mobility is graded clinically by applying pressure with the ends of 2 metal instruments (e.g. dental mirrors) and trying to rock a tooth gently in a bucco-lingual direction (towards the tongue and outwards again). Normal, physiologic tooth mobility of about 0.25 mm is present in health. This is because the tooth is not fused to the bones of the jaws, but is connected to the sockets by the periodontal ligament. Abnormal, pathologic tooth mobility occurs when the attachment of the periodontal ligament to the tooth is reduced (attachment loss), or if the periodontal ligament is inflamed. Tooth mobility is measured and graduated from 0-3. Grade 0: No apparent mobility Grade 1: Perceptible mobility \<1mm in buccolingual direction Grade 2: \>1mm but \<2mm Grade 3: \>2mm or depressibility in the socket

Outcome measures

Outcome measures
Measure
Lower Jaw Pockets + Treatment
n=63 pockets
Periodontal pockets situated in the lower jaw which received a treatment of SRP + Pocket-X gel.
Lower Jaw Pockets - Control
n=63 pockets
Periodontal pockets situated in the lower jaw which received a tratment of SRP only.
Upper Jaw Pockets + Treatment
n=109 pockets
Periodontal pockets situated in the upper jaw which received a treatment of SRP + Pocket-X gel.
Upper Jaw Pockets + Control
n=109 pockets
Periodontal pockets situated in the upper jaw which received a treatment of SRP alone.
Change in Mobility Grade
Mobility at baseline
0.19 mobility grade
Standard Deviation 0.50
0.19 mobility grade
Standard Deviation 0.53
0.18 mobility grade
Standard Deviation 0.51
0.19 mobility grade
Standard Deviation 0.52
Change in Mobility Grade
Mobility after 3 months
0.05 mobility grade
Standard Deviation 0.21
0.14 mobility grade
Standard Deviation 0.50
0.05 mobility grade
Standard Deviation 0.23
0.15 mobility grade
Standard Deviation 0.38
Change in Mobility Grade
Mobility after 6 months
0 mobility grade
Standard Deviation 0
0.01 mobility grade
Standard Deviation 0.12
0.01 mobility grade
Standard Deviation 0.10
0.12 mobility grade
Standard Deviation 0.35

Adverse Events

SRP+Pocket-X Gel, Split-mouth

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Head of QA/RA

Prudentix Ltd.

Phone: +972-72-394-22-24

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place